Trial Profile
Effects of aspirin/dipyridamole (Asasantin retard) on platelet function, oxidative stress and peripheral vascular function in patients with primary Raynaud's phenomenon and systemic sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Aspirin/dipyridamole (Primary)
- Indications Raynaud's disease; Systemic scleroderma
- Focus Pharmacodynamics
- 14 Dec 2015 New trial record